SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of September 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Rui (Kerrie), Chief Financial Officer, on September 11, 2019. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists solely of the cover page, signature block, and an exhibit index referencing a press release (Exhibit 99.1), but the content of the press release is not included in the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are present in the provided excerpt.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The provided content is limited to administrative filing details and does not contain the substantive disclosures typically found in the referenced press release.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release) as the primary source of material information for this period.
- Confirm the registrant's identity as Hexindai Inc., noting the discrepancy with the "Akso Health Group" label in the request metadata.
- Check for subsequent filings or the full press release to obtain actual financial performance data for September 2019.
- Review the company's Form 20-F for broader annual context, as indicated by the checkmark on the cover page.